GB0025209D0 - Treatment of cancers - Google Patents

Treatment of cancers

Info

Publication number
GB0025209D0
GB0025209D0 GB0025209A GB0025209A GB0025209D0 GB 0025209 D0 GB0025209 D0 GB 0025209D0 GB 0025209 A GB0025209 A GB 0025209A GB 0025209 A GB0025209 A GB 0025209A GB 0025209 D0 GB0025209 D0 GB 0025209D0
Authority
GB
United Kingdom
Prior art keywords
cancers
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0025209A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Priority to GB0025209A priority Critical patent/GB0025209D0/en
Priority to AU14023/01A priority patent/AU780417B2/en
Priority to PCT/GB2000/004349 priority patent/WO2001035974A2/en
Priority to DE60035120T priority patent/DE60035120T2/en
Priority to DK00976137T priority patent/DK1229922T3/en
Priority to ES00976137T priority patent/ES2288486T3/en
Priority to PL355335A priority patent/PL200922B1/en
Priority to NZ518847A priority patent/NZ518847A/en
Priority to KR10-2002-7006155A priority patent/KR100518986B1/en
Priority to CZ20021697A priority patent/CZ302498B6/en
Priority to AT00976137T priority patent/ATE363910T1/en
Priority to CA002391502A priority patent/CA2391502A1/en
Priority to EP00976137A priority patent/EP1229922B1/en
Priority to BR0015811-9A priority patent/BR0015811A/en
Priority to IL14948800A priority patent/IL149488A0/en
Priority to CN00818404A priority patent/CN1423564A/en
Priority to MXPA02004862A priority patent/MXPA02004862A/en
Priority to PT00976137T priority patent/PT1229922E/en
Priority to HU0203906A priority patent/HUP0203906A2/en
Priority to SK659-2002A priority patent/SK287762B6/en
Priority to SI200030960T priority patent/SI1229922T1/en
Priority to RU2002115864/14A priority patent/RU2261104C2/en
Priority to JP2001537965A priority patent/JP2003514025A/en
Publication of GB0025209D0 publication Critical patent/GB0025209D0/en
Priority to CNA018204740A priority patent/CN1479622A/en
Priority to CA002424823A priority patent/CA2424823A1/en
Priority to AU2001294024A priority patent/AU2001294024C1/en
Priority to HU0302293A priority patent/HUP0302293A3/en
Priority to AT01974510T priority patent/ATE299028T1/en
Priority to BR0114604-1A priority patent/BR0114604A/en
Priority to NZ525196A priority patent/NZ525196A/en
Priority to US10/398,835 priority patent/US7507766B2/en
Priority to AU9402401A priority patent/AU9402401A/en
Priority to ES01974510T priority patent/ES2243555T3/en
Priority to KR10-2003-7005081A priority patent/KR20030038812A/en
Priority to MXPA03003230A priority patent/MXPA03003230A/en
Priority to EP01974510A priority patent/EP1330254B1/en
Priority to RU2003113210/14A priority patent/RU2003113210A/en
Priority to DE60111858T priority patent/DE60111858T2/en
Priority to CZ2003993A priority patent/CZ2003993A3/en
Priority to PL01361179A priority patent/PL361179A1/en
Priority to PCT/GB2001/004555 priority patent/WO2002030441A2/en
Priority to IL15527301A priority patent/IL155273A0/en
Priority to JP2002533881A priority patent/JP2004510824A/en
Priority to NO20022293A priority patent/NO330719B1/en
Priority to BG106714A priority patent/BG65381B1/en
Priority to HK02106981.6A priority patent/HK1045648B/en
Priority to NO20031673A priority patent/NO20031673L/en
Priority to HK03106440.0A priority patent/HK1054191A1/en
Priority to CY20071101110T priority patent/CY1106825T1/en
Priority to US12/342,478 priority patent/US20090298752A1/en
Priority to JP2009255266A priority patent/JP2010031043A/en
Ceased legal-status Critical Current

Links

GB0025209A 1999-11-15 2000-10-13 Treatment of cancers Ceased GB0025209D0 (en)

Priority Applications (51)

Application Number Priority Date Filing Date Title
GB0025209A GB0025209D0 (en) 2000-10-13 2000-10-13 Treatment of cancers
AU14023/01A AU780417B2 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
PCT/GB2000/004349 WO2001035974A2 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
DE60035120T DE60035120T2 (en) 1999-11-15 2000-11-15 TREATMENT OF CANCER DISORDERS BY APLIDINE
DK00976137T DK1229922T3 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
ES00976137T ES2288486T3 (en) 1999-11-15 2000-11-15 TREATMENT OF CANCERES WITH APLIDINA.
PL355335A PL200922B1 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
NZ518847A NZ518847A (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
KR10-2002-7006155A KR100518986B1 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
CZ20021697A CZ302498B6 (en) 1999-11-15 2000-11-15 Pharmaceutical composition containing aplidine for treating cancer diseases
AT00976137T ATE363910T1 (en) 1999-11-15 2000-11-15 TREATMENT OF CANCER DISEASES BY APLIDINE
CA002391502A CA2391502A1 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
EP00976137A EP1229922B1 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
BR0015811-9A BR0015811A (en) 1999-11-15 2000-11-15 Treatment of cancers with aplidine
IL14948800A IL149488A0 (en) 1999-11-15 2000-11-15 Pharmaceutical compositions containing aplidine
CN00818404A CN1423564A (en) 1999-11-15 2000-11-15 APLIDINE treatment of cancers
MXPA02004862A MXPA02004862A (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers.
PT00976137T PT1229922E (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
HU0203906A HUP0203906A2 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
SK659-2002A SK287762B6 (en) 1999-11-15 2000-11-15 Use of aplidine in preparation of pharmaceutical composition for treating cancer
SI200030960T SI1229922T1 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
RU2002115864/14A RU2261104C2 (en) 1999-11-15 2000-11-15 Treatment of malignant tumor with aplidine
JP2001537965A JP2003514025A (en) 1999-11-15 2000-11-15 Aplidine treatment for cancer
CNA018204740A CN1479622A (en) 2000-10-12 2001-10-12 Treatment of cancers by aplidine in conjunction with myoprotector
CA002424823A CA2424823A1 (en) 2000-10-12 2001-10-12 Treatment of cancers by aplidine in conjunction with a myoprotector
AU2001294024A AU2001294024C1 (en) 2000-10-12 2001-10-12 Treatment of cancers by aplidine in conjunction with a myoprotector
HU0302293A HUP0302293A3 (en) 2000-10-12 2001-10-12 Treatment of cancers by aplidine in conjunction with a myoprotector
AT01974510T ATE299028T1 (en) 2000-10-12 2001-10-12 TREATMENT OF CANCER DISEASES WITH APLIDINE IN COMBINATION WITH CARNITINE OR ACETYLCARNITINE
BR0114604-1A BR0114604A (en) 2000-10-12 2001-10-12 Cancer treatment
NZ525196A NZ525196A (en) 2000-10-12 2001-10-12 Treatment of cancers by aplidine in conjunction with a myoprotector
US10/398,835 US7507766B2 (en) 2000-10-12 2001-10-12 Treatment of cancers
AU9402401A AU9402401A (en) 2000-10-12 2001-10-12 Treatment of cancers
ES01974510T ES2243555T3 (en) 2000-10-12 2001-10-12 CANCER TREATMENT BY APLIDINE IN CONJUNCTION WITH CARNITINE OR ACETILCARNITINE.
KR10-2003-7005081A KR20030038812A (en) 2000-10-12 2001-10-12 Treatment of cancers
MXPA03003230A MXPA03003230A (en) 2000-10-12 2001-10-12 Treatment of cancers by aplidine in conjunction with a myoprotector.
EP01974510A EP1330254B1 (en) 2000-10-12 2001-10-12 Treatment of cancers by aplidine in conjunction with carnitine or acetylcarnitine
RU2003113210/14A RU2003113210A (en) 2000-10-12 2001-10-12 TREATMENT OF CANCER DISEASES
DE60111858T DE60111858T2 (en) 2000-10-12 2001-10-12 TREATMENT OF CANCER DISORDERS WITH APLIDINE IN COMBINATION WITH CARNITINE OR ACETYLCARNITINE
CZ2003993A CZ2003993A3 (en) 2000-10-12 2001-10-12 Medicament for treating cancer by administration of aplidine or aplidine analog and bone musculature protector
PL01361179A PL361179A1 (en) 2000-10-12 2001-10-12 Treatment of cancers
PCT/GB2001/004555 WO2002030441A2 (en) 2000-10-12 2001-10-12 Treatment of cancers by aplidine in conjunction with a myoprotector
IL15527301A IL155273A0 (en) 2000-10-12 2001-10-12 Pharmaceutical compositions comprising an aplidine compound
JP2002533881A JP2004510824A (en) 2000-10-12 2001-10-12 Cancer Treatment
NO20022293A NO330719B1 (en) 1999-11-15 2002-05-14 Use of aplidine in the manufacture of a pharmaceutical composition for the treatment of cancer in a human patient
BG106714A BG65381B1 (en) 1999-11-15 2002-05-18 Use of aplidine in the preparation of a pharmaceutical composition for treatment of cancer
HK02106981.6A HK1045648B (en) 1999-11-15 2002-09-25 Aplidine treatment of cancers
NO20031673A NO20031673L (en) 2000-10-12 2003-04-11 Treatment of cancer
HK03106440.0A HK1054191A1 (en) 2000-10-12 2003-09-10 Treatment of cancers by aplidine in conjunction with a myoprotector
CY20071101110T CY1106825T1 (en) 1999-11-15 2007-08-30 TREATMENT OF CANCER WITH APLIDINE
US12/342,478 US20090298752A1 (en) 1999-11-15 2008-12-23 Aplidine treatment of cancers
JP2009255266A JP2010031043A (en) 2000-10-12 2009-11-06 Treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0025209A GB0025209D0 (en) 2000-10-13 2000-10-13 Treatment of cancers

Publications (1)

Publication Number Publication Date
GB0025209D0 true GB0025209D0 (en) 2000-11-29

Family

ID=9901281

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0025209A Ceased GB0025209D0 (en) 1999-11-15 2000-10-13 Treatment of cancers

Country Status (1)

Country Link
GB (1) GB0025209D0 (en)

Similar Documents

Publication Publication Date Title
GB0028264D0 (en) Well treatment
GB0028269D0 (en) Well treatment
AU5464601A (en) Treatment of scale
EP1320376A4 (en) Treatment of prostate cancer
PL362855A1 (en) Improved treatment
EG25829A (en) Novel treatment
IL151833A0 (en) Improved treatment of neovascularization
GB0030845D0 (en) Novel treatment
AU5000001A (en) Treatment of vitiligo
AU9402401A (en) Treatment of cancers
IL149281A0 (en) Treatment of cancer
GB0026015D0 (en) Cancer treatment
GB9819999D0 (en) Treatment of cancer
GB2381455B (en) Treatment of burns
EP1303281A4 (en) Methods of treatment
GB0025209D0 (en) Treatment of cancers
GB0031321D0 (en) Treatment
GB0029125D0 (en) Novel treatment
GB9911183D0 (en) Treatment of cancers
GB0008161D0 (en) Treatment of cancer
GB0127006D0 (en) Treatment of moccasion seam
GB9911346D0 (en) Treatment of cancers
GB9918534D0 (en) Treatment of cancers
GB9927005D0 (en) Treatment of cancers
GB0017952D0 (en) Treatment of dyskinesia

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)